Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Boosted compression for lower limb edema

Official title: Effectiveness of BoostEd COMpresson for the Treatment of Lower Limb Chronic Edema (BECOME): a Pragmatic Multi-centric Randomized Trial

Run by Universiteit Antwerpen · NCT07708662 · Data updated 2026-11-12

This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorUniversiteit Antwerpen
Academic / other
Locations4 sites (Edegem, Antwerp and 3 other locations)
StatusRecruiting
StartedJune 2026
Main results expectedJune 2029
Study endsDecember 31, 2029
Registry record updatedJuly 16, 2026
Trial IDNCT07708662 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with chronic lower-limb edema or lymphedema (more than 3 months) who can understand Dutch and are suitable for conservative compression therapy.

Probably not a fit

Patients with significant arterial disease, wounds in the treated area, or conditions making compression therapy unsuitable may not benefit and could be at risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pragmatic interventional study compares boosted compression added to standard complex decongestive therapy (CDT) against CDT alone for lower-limb chronic edema. The boosted approach uses three daily applications of a short-stretch bandage during an intensive treatment phase, delivered by patients or care providers under therapist supervision. Primary outcomes include days to reach a non-pitting state, edema volume by circumference, and tissue water content at the start and end of the intensive phase. A secondary aim is to determine whether any edema reduction is maintained during the subsequent maintenance phase, in a non-inferiority framework. Real-world clinical settings and multiple European centers are involved to reflect routine practice.

Why it matters

Potential benefit: If successful, boosted compression could shorten intensive treatment time and improve long-term edema control for patients with chronic leg edema.

How similar studies have gone: Previous studies on enhanced compression strategies show potential but this pragmatic, multi-center approach in real-world settings is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Patients suffering from chronic edema ( \> 3 months) of the lower extremity with a positive pitting sign and a conservative treatment is prescribed.

  -≥ 18 years old
* BMI is \<36
* Able to understand and follow instructions in Dutch

Exclusion criteria:

* All treatable causes of chronic edema, such as hormonal disturbances (e.g. thyroid dysfunction), protein abnormalities (especially Albumin), cardiac insufficiency, nephrological conditions, drug-induced edema or peripheral arterial disease.
* Peripheral arterial disease (ABI \< 0.55)
* The patient is allergic for one of the products we use during the treatment, and no alternative is available
* The patient has wounds at the level of the treated edema zone.
* The patient is currently receiving treatment within the convention "lymfoedeem" according to the Belgian Health insurance (RIZIV-INAMI).
* The patient is not able to give written consent.

Where it's running

  • Antwerp University Hospital
    Edegem, Antwerp, Belgium
    Recruiting
  • University of Antwerp
    Wilrijk, Antwerp, Belgium
    Recruiting
  • University Hospital Leuven
    Leuven, Brabant, Belgium
    Recruiting
  • Ghent University Hospital
    Ghent, East Flanders, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.